TrialAntimicrobial agents and chemotherapy2024

A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness.

David Plotnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.